Manufacturer
Merck Sharp & Dohme NDC Codes
Finished products listed with the FDA under labeler names that contain “Merck Sharp & Dohme”.
Most-listed names
By number of FDA listings (strengths, forms and packages), not by sales.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Antiveninlatrodectus mactans | — | Kit | Merck Sharp & Dohme LLC | 0006-5424 |
| Bcg Vaccinebacillus calmette-guerin substrain tice live antigen | Bacillus calmette-guerin substrain tice live antigen 50 mg/1 | Injection, Powder, Lyophilized, For solutionPercutaneous | Merck Sharp & Dohme LLC | 0052-0603 |
| Belsomrasuvorexant | Suvorexant 5 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-0005 |
| Belsomrasuvorexant | Suvorexant 10 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-0033 |
| Belsomrasuvorexant | Suvorexant 15 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-0325 |
| Belsomrasuvorexant | Suvorexant 20 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-0335 |
| Bridionsugammadex | Sugammadex sodium 100 mg/mL | Injection, SolutionIntravenous | Merck Sharp & Dohme LLC | 0006-5423 |
| Bridionsugammadex | Sugammadex sodium 100 mg/mL | Injection, SolutionIntravenous | Merck Sharp & Dohme LLC | 0006-5425 |
| Cancidascaspofungin acetate | Caspofungin acetate 5 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | Merck Sharp & Dohme LLC | 0006-3822 |
| Cancidascaspofungin acetate | Caspofungin acetate 7 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | Merck Sharp & Dohme LLC | 0006-3823 |
| Capvaxivepneumococcal 21-valent conjugate vaccine | Streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen 4 ug/.5mL + 21 more ingredients | Injection, SolutionIntramuscular | Merck Sharp & Dohme LLC | 0006-4347 |
| Delstrigodoravirine, lamivudine, and tenofovir disoproxil fumarate | Doravirine 100 mg/1 + 2 more ingredients | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 0006-5007 |
| Dificidfidaxomicin | Fidaxomicin 200 mg/1 | Tablet, Film coatedOral | Merck Sharp & Dohme LLC | 52015-080 |
| Dificidfidaxomicin | Fidaxomicin 200 mg/5mL | Granule, For suspensionOral | Merck Sharp & Dohme LLC | 52015-700 |
| Emendaprepitant | Aprepitant 80 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0461 |
| Emendaprepitant | Aprepitant 125 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0462 |
| Emendaprepitant | Aprepitant 40 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0464 |
| Emendfosaprepitant dimeglumine | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | Merck Sharp & Dohme LLC | 0006-3061 |
| Emendaprepitant | Aprepitant 125 mg/1 | Powder, For suspensionOral | Merck Sharp & Dohme LLC | 0006-3066 |
| Emendaprepitant | — | Kit | Merck Sharp & Dohme LLC | 0006-3862 |
| Enflonsiaclesrovimab | Clesrovimab 150 mg/mL | Injection, SolutionIntramuscular | Merck Sharp & Dohme LLC | 0006-5073 |
| Ervebozaire ebolavirus (strain kikwit-95) envelope glycoprotein | Zaire ebolavirus (Strain kikwit-95) envelope glycoprotein 72000000 [PFU]/mL | Injection, SolutionIntramuscular | Merck Sharp & Dohme LLC | 0006-4293 |
| Gardasilhuman papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 20 ug/.5mL + 3 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4045 |
| Gardasilhuman papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 20 ug/.5mL + 3 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4109 |
| Gardasil 9human papillomavirus 9-valent vaccine, recombinant | Human papillomavirus type 6 l1 capsid protein antigen 30 ug/.5mL + 8 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4119 |